1 active not recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Microvillus inclusion disease: new trials by email Literature Review of Microvillus inclusion disease trials Research Report on Microvillus inclusion disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID) Crofelemer Powder for Oral Solution, Placebo Powder for Oral Solution - Microvillus Inclusion Disease, Congenital Disorders | Phase 2 / Phase 3 | Active not recruiting | Napo Pharmaceuticals, Inc. | 6 | 2025-05-01 | 2026-06-09 |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Rare Diseases (1)
Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Solutions (1)
Napo Pharmaceuticals, Inc. (1)
Italy (1) · United Arab Emirates (1) · United States (1)